Journey Medical Corp financial data

Symbol
DERM on Nasdaq
Industry
Pharmaceutical Preparations
Location
9237 E Via De Ventura Blvd., Suite 105, Scottsdale, Arizona
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 119 % +22.2%
Quick Ratio 25.4 % +26.3%
Debt-to-equity 343 % -47.1%
Return On Equity 5.44 %
Return On Assets 1.23 %
Operating Margin 2.73 %

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 11.6M shares
Entity Public Float 12.3M USD -53.7%
Weighted Average Number of Shares Outstanding, Basic 20M shares +11%
Weighted Average Number of Shares Outstanding, Diluted 20M shares +11%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 77.7M USD +26.4%
Revenue from Contract with Customer, Excluding Assessed Tax 58.4M USD -4.37%
Cost of Revenue 25.8M USD -11.5%
Research and Development Expense 12.5M USD +15.2%
Costs and Expenses 75.6M USD -23%
Operating Income (Loss) 2.12M USD +61.8%
Nonoperating Income (Expense) -1.06M USD +57.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.06M USD +59.8%
Income Tax Expense (Benefit) 95K USD +850%
Net Income (Loss) Attributable to Parent 843K USD +59.8%
Earnings Per Share, Basic 0.12 USD/shares +63%
Earnings Per Share, Diluted 0.12 USD/shares +63%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 23.9M USD +191%
Accounts Receivable, after Allowance for Credit Loss, Current 10.5M USD -37.5%
Inventory, Net 9.69M USD -20.4%
Assets, Current 46.5M USD -2.54%
Operating Lease, Right-of-Use Asset 55K USD -62.3%
Intangible Assets, Net (Excluding Goodwill) 18.7M USD -14.9%
Other Assets, Noncurrent 6K USD 0%
Assets 65.2M USD -6.54%
Accounts Payable, Current 14.6M USD -54%
Accrued Liabilities, Current 16M USD -31.5%
Liabilities, Current 34.1M USD -49.9%
Operating Lease, Liability, Noncurrent 9K USD -91.7%
Liabilities 53.9M USD -22.7%
Retained Earnings (Accumulated Deficit) -86.2M USD +0.97%
Stockholders' Equity Attributable to Parent 11.3M USD
Liabilities and Equity 65.2M USD -6.54%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.02M USD -425%
Net Cash Provided by (Used in) Financing Activities 1.64M USD +3048%
Net Cash Provided by (Used in) Investing Activities -5M USD +75%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 11.6M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.38M USD +42.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 23.9M USD +40.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 267K USD -50.1%
Deferred Tax Assets, Valuation Allowance 20.2M USD +4.39%
Deferred Tax Assets, Gross 20.2M USD -0.87%
Operating Lease, Liability 59K USD -61.7%
Lessee, Operating Lease, Liability, to be Paid 60K USD -62.7%
Operating Lease, Liability, Current 59K USD -37.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9K USD -91.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 9K USD -91.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -85.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9K USD
Deferred Tax Assets, Operating Loss Carryforwards 4.38M USD -33.2%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 106K USD +19%
Additional Paid in Capital 97.5M USD +12%
Amortization of Intangible Assets 814K USD -23.9%
Deferred Tax Assets, Net of Valuation Allowance 25K USD -97.6%
Share-based Payment Arrangement, Expense 4.17M USD -5.23%
Interest Expense 1.6M USD -30%